June 13, 2016 Intelligence: Late Breaking Lab News

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

Life insurers are adopting healthcare big data as part of their underwriting process and clinical laboratory test data has an important role. Quest Diagnostics Incorporated participates in this business line. Huffington Post recently published a story on this topic and identified companies that life insurers use to access data about prescription drug histories and lab test results. ExamOne is a division of Quest Diagnostics and its “QuestCheck” service queries the clinical lab database of Quest to “give insurers results from doctor-ordered tests.”

MORE ON: Life Insurers

Consumers may be surprised to learn the majority of life insurance companies use medical information from MIB Group, with more than half using prescription databases, lab results, and motor vehicle records. All of this big data feeds into algorithms that life insurers use to make underwriting decisions.


It took the Canadian regulatory agency Health Canada only 18 years to finalize its guidance for labeling in vitro diagnostic (IVD) devices. It was 1998 when it released the draft version. The final guidance, issued on April 22, includes new considerations for electronic labeling, IVDs with small containers, blood glucose monitors, and information on complying with Canada’s Official Languages Act (which requires product labels to be written in both French and English). There are some lab managers who would like to see the FDA take this long to produce its final guidance on laboratory-developed tests!


  • George Jabboure Netto, MD, was selected to be the next chair of the Department of Pathology at the University of Alabama-Birmingham’s School of Medicine, beginning on October 1. He has spent the majority of his career at Johns Hopkins University, starting in 2005.
  • Elissa Passiment, EdM., CLS, long-time Executive Vice President of the American Society for Clinical Laboratory Science, retired this month. She will continue to act as a consultant on regulatory affairs. Prior to joining ASCLS in 1995, she worked with McFaul & Lyons.
  • James Flanigan is the new Executive Vice President at ASCLS. He previously held positions at the Society of Critical Care Medicine, and Phi Kappa Theta International Fraternity, among other associations.

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about …

…the upcoming webinar on June 23 about how labs can use LinkedIn and social media to attract and retain skilled managers and clinical laboratory scientists. Information is at www.darkdaily.com.

You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.

That’s all the insider intelligence for this report. Look for the next briefing on Tuesday, July 5, 2016.

Screenshot 2016-06-16 15.58.06



What’s the Near Future for Digital Pathology? Status with FDA Clearance and other Issues

 Midwest Health System Lab Makes Big Inroads in Growing Market Share and Profits.

∗ Why Millenial-Generation Pathologists Are Bringing New Perspectives to Lab Operations

 For more information, visit www.darkreport.com.

Sign up for our FREE news service!

Delivered directory to your desktop, DARK Daily is news, analysis and more.

Visit www.darkdaily.com




Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.